vs

Side-by-side financial comparison of CASTLE BIOSCIENCES INC (CSTL) and LINDSAY CORP (LNN). Click either name above to swap in a different company.

LINDSAY CORP is the larger business by last-quarter revenue ($150.7M vs $83.7M, roughly 1.8× CASTLE BIOSCIENCES INC). LINDSAY CORP runs the higher net margin — 11.0% vs -17.4%, a 28.3% gap on every dollar of revenue. On growth, CASTLE BIOSCIENCES INC posted the faster year-over-year revenue change (-4.9% vs -6.1%). Over the past eight quarters, LINDSAY CORP's revenue compounded faster (1.3% CAGR vs -1.9%).

Castle Biosciences Inc. is a commercial-stage diagnostic firm that develops and markets proprietary, clinically actionable tests for dermatological conditions such as melanoma and other skin cancers, plus rare diseases. It operates mainly in the U.S. healthcare market, focusing on segments with high unmet need for more accurate diagnostics to guide treatment choices.

Lindsay Corporation, formerly known as Lindsay Manufacturing Co., is a manufacturer of Zimmatic brand center pivot irrigation systems, based in Omaha, Nebraska, United States. It also manufactures farm and construction machinery, as well as road and railroad infrastructure equipment. At August 31, 2008, the company had 1,239 employees.

CSTL vs LNN — Head-to-Head

Bigger by revenue
LNN
LNN
1.8× larger
LNN
$150.7M
$83.7M
CSTL
Growing faster (revenue YoY)
CSTL
CSTL
+1.2% gap
CSTL
-4.9%
-6.1%
LNN
Higher net margin
LNN
LNN
28.3% more per $
LNN
11.0%
-17.4%
CSTL
Faster 2-yr revenue CAGR
LNN
LNN
Annualised
LNN
1.3%
-1.9%
CSTL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CSTL
CSTL
LNN
LNN
Revenue
$83.7M
$150.7M
Net Profit
$-14.5M
$16.5M
Gross Margin
33.3%
Operating Margin
13.0%
Net Margin
-17.4%
11.0%
Revenue YoY
-4.9%
-6.1%
Net Profit YoY
43.8%
-3.7%
EPS (diluted)
$-0.49
$1.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSTL
CSTL
LNN
LNN
Q1 26
$83.7M
Q4 25
$87.0M
$150.7M
Q3 25
$83.0M
$149.0M
Q2 25
$86.2M
$165.7M
Q1 25
$88.0M
$183.8M
Q4 24
$86.3M
$160.5M
Q3 24
$85.8M
$149.4M
Q2 24
$87.0M
$133.7M
Net Profit
CSTL
CSTL
LNN
LNN
Q1 26
$-14.5M
Q4 25
$16.5M
Q3 25
$-501.0K
$10.8M
Q2 25
$4.5M
$19.5M
Q1 25
$-25.8M
$26.6M
Q4 24
$17.2M
Q3 24
$2.3M
$12.7M
Q2 24
$8.9M
$20.4M
Gross Margin
CSTL
CSTL
LNN
LNN
Q1 26
Q4 25
79.0%
33.3%
Q3 25
77.5%
30.0%
Q2 25
79.5%
32.4%
Q1 25
81.4%
34.0%
Q4 24
81.3%
31.1%
Q3 24
81.8%
30.6%
Q2 24
83.3%
34.8%
Operating Margin
CSTL
CSTL
LNN
LNN
Q1 26
Q4 25
-4.4%
13.0%
Q3 25
-8.2%
7.6%
Q2 25
-4.9%
14.4%
Q1 25
-31.7%
17.5%
Q4 24
4.7%
13.0%
Q3 24
5.9%
9.0%
Q2 24
5.8%
14.9%
Net Margin
CSTL
CSTL
LNN
LNN
Q1 26
-17.4%
Q4 25
11.0%
Q3 25
-0.6%
7.3%
Q2 25
5.2%
11.8%
Q1 25
-29.4%
14.5%
Q4 24
10.7%
Q3 24
2.6%
8.5%
Q2 24
10.3%
15.2%
EPS (diluted)
CSTL
CSTL
LNN
LNN
Q1 26
$-0.49
Q4 25
$-0.06
$1.54
Q3 25
$-0.02
$0.99
Q2 25
$0.15
$1.78
Q1 25
$-0.90
$2.44
Q4 24
$0.32
$1.57
Q3 24
$0.08
$1.16
Q2 24
$0.31
$1.85

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSTL
CSTL
LNN
LNN
Cash + ST InvestmentsLiquidity on hand
$63.8M
$199.6M
Total DebtLower is stronger
$10.1M
$115.2M
Stockholders' EquityBook value
$461.4M
$518.2M
Total Assets
$547.8M
$828.4M
Debt / EquityLower = less leverage
0.02×
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSTL
CSTL
LNN
LNN
Q1 26
$63.8M
Q4 25
$299.5M
$199.6M
Q3 25
$287.5M
$250.6M
Q2 25
$275.9M
$210.8M
Q1 25
$275.2M
$186.7M
Q4 24
$293.1M
$194.1M
Q3 24
$95.0M
$190.9M
Q2 24
$85.6M
$152.7M
Total Debt
CSTL
CSTL
LNN
LNN
Q1 26
$10.1M
Q4 25
$10.1M
$115.2M
Q3 25
$10.0M
$115.3M
Q2 25
$10.0M
$115.3M
Q1 25
$10.0M
$115.4M
Q4 24
$10.0M
$115.4M
Q3 24
$10.0M
$115.5M
Q2 24
$10.0M
$115.5M
Stockholders' Equity
CSTL
CSTL
LNN
LNN
Q1 26
$461.4M
Q4 25
$470.9M
$518.2M
Q3 25
$467.0M
$532.9M
Q2 25
$455.4M
$528.8M
Q1 25
$440.3M
$516.4M
Q4 24
$455.8M
$488.5M
Q3 24
$441.1M
$480.9M
Q2 24
$423.9M
$480.0M
Total Assets
CSTL
CSTL
LNN
LNN
Q1 26
$547.8M
Q4 25
$578.6M
$828.4M
Q3 25
$562.8M
$840.8M
Q2 25
$544.7M
$840.9M
Q1 25
$501.7M
$814.2M
Q4 24
$531.2M
$771.0M
Q3 24
$514.6M
$760.2M
Q2 24
$487.3M
$758.1M
Debt / Equity
CSTL
CSTL
LNN
LNN
Q1 26
0.02×
Q4 25
0.02×
0.22×
Q3 25
0.02×
0.22×
Q2 25
0.02×
0.22×
Q1 25
0.02×
0.22×
Q4 24
0.02×
0.24×
Q3 24
0.02×
0.24×
Q2 24
0.02×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSTL
CSTL
LNN
LNN
Operating Cash FlowLast quarter
$-22.1M
$-597.0K
Free Cash FlowOCF − Capex
$-15.1M
FCF MarginFCF / Revenue
-10.0%
Capex IntensityCapex / Revenue
9.6%
Cash ConversionOCF / Net Profit
-0.04×
TTM Free Cash FlowTrailing 4 quarters
$62.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSTL
CSTL
LNN
LNN
Q1 26
$-22.1M
Q4 25
$26.9M
$-597.0K
Q3 25
$22.6M
$64.0M
Q2 25
$20.8M
$35.0M
Q1 25
$-6.0M
$12.3M
Q4 24
$24.4M
$21.6M
Q3 24
$23.3M
$53.1M
Q2 24
$24.0M
$30.5M
Free Cash Flow
CSTL
CSTL
LNN
LNN
Q1 26
Q4 25
$19.7M
$-15.1M
Q3 25
$7.8M
$49.8M
Q2 25
$11.6M
$25.7M
Q1 25
$-10.8M
$2.5M
Q4 24
$16.8M
$12.5M
Q3 24
$17.0M
$47.7M
Q2 24
$18.8M
$25.8M
FCF Margin
CSTL
CSTL
LNN
LNN
Q1 26
Q4 25
22.7%
-10.0%
Q3 25
9.4%
33.4%
Q2 25
13.4%
15.5%
Q1 25
-12.2%
1.4%
Q4 24
19.5%
7.8%
Q3 24
19.8%
31.9%
Q2 24
21.6%
19.3%
Capex Intensity
CSTL
CSTL
LNN
LNN
Q1 26
Q4 25
8.3%
9.6%
Q3 25
17.9%
9.6%
Q2 25
10.7%
5.6%
Q1 25
5.4%
5.3%
Q4 24
8.8%
5.7%
Q3 24
7.4%
3.6%
Q2 24
6.0%
3.6%
Cash Conversion
CSTL
CSTL
LNN
LNN
Q1 26
Q4 25
-0.04×
Q3 25
5.92×
Q2 25
4.60×
1.79×
Q1 25
0.46×
Q4 24
1.26×
Q3 24
10.29×
4.17×
Q2 24
2.69×
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSTL
CSTL

Segment breakdown not available.

LNN
LNN

Transferred At Point In Time$133.2M88%
Infrastructure$13.4M9%
Transferred Over Time$8.0M5%

Related Comparisons